Recent News

The Chase Group and Isis Partnership Results in Recruitment of Neurologist

Dr. Roger Lane was successfully recruited by The Chase Group to join Isis Pharmaceuticals as the new Vice President of Clinical Development in Neurology. Continue Reading →

AbbVie Gains Top Talent

AbbVie recently hired two outstanding candidates identified by The Chase Group. Susan Sciotto-Brown joined AbbVie in their R&D facility in Worcester, Massachusetts and has assumed… Continue Reading →

Successful Conclusion to Search for Rare Disease Specialist

After an extensive search, The Chase Group announces the recruitment of Dr. Eugene Schneider for the Executive Director, Clinical Development, Rare Diseases position at Isis… Continue Reading →

ImClone Engages The Chase Group

The Chase Group has been retained by ImClone to begin searching for the Senior Director/Associate Vice President lead position for breast cancer clinical development. Continue Reading →

Eisai Retains Chase for VP Neuroscience

Eisai, Inc. has retained The Chase Group to recruit the Vice President of Neuroscience, Clinical Team position. Continue Reading →

AbbVie Hires Global Regulatory Lead

The Chase Group announces the recruitment of Toni Glinsey, joining the team at AbbVie as Global Regulatory Lead, Strategy. Continue Reading →

Search Begins for Oncology Clinical Research

Eisai, Co., Ltd., has once again engaged the services of The Chase Group to build their clinical research team in oncology. Continue Reading →

Chase Takes on Clinical Leadership Positions in Cardiovascular and Rare Diseases

Isis Pharmaceuticals has partnered with The Chase Group to fill two positions in order to build their clinical leadership team in the cardiovascular and rare… Continue Reading →